Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
Clinical trial NCT02913105 · TERMINATED
Trial details
- NCT number
- NCT02913105
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-24
- Primary completion
- 2018-09-19
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.